Data on Alcon’s products across cataract, refractive, diagnostics and ocular health will be featured in presentations during the meeting Prospective analyses and studies demonstrate sustained ...

GENEVA--(BUSINESS WIRE)-- Regulatory News: Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that Vivity ®, the most widely implanted 9 extended ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that Vivity®, the most widely implanted9 extended depth of focus (EDOF) intraocular ...

The following is a summary of “Comparing an advanced monofocal with a non-diffractive extended depth of focus intraocular lens using a mini-monovision approach: Comparing advanced intraocular lenses ...

A 2015–2016 cluster of postsurgical TASS inflammation cases led to manufacturing changes — newly produced lenses show notably low rates for inflammation. After manufacturing advances, a multifocal ...

According to the company, the milestone underscores Vivity’s wavefront-shaping technology, which simplifies presbyopia correction for surgeons and patients. Alcon announced the AcrySof IQ Vivity and ...

Alcon is a global leader in IOLs and controls 40%-50% of the market, by our estimate. Its AcrySof IQ IOL, which was launched in 1994, has been implanted in more than 135 million eyes, making it the ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today revealed final data from its Vivity ® Registry Study, which monitored ...

These results and additional data are being discussed in 11 sessions with world-renowned surgeons at the 41 st Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), currently ...

Alcon, the global leader in eye care dedicated to helping people see brilliantly, revealed final data from its Vivity® Registry Study, which monitored real-world patient experiences for up to 12 ...